These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33813611)

  • 1. Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study.
    Spinella TC; Stewart SH; Naugler J; Yakovenko I; Barrett SP
    Psychopharmacology (Berl); 2021 Jul; 238(7):1965-1977. PubMed ID: 33813611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Cannabidiol Expectancy on Cortisol Responsivity in the Context of Acute Stress: Associations with Biological Sex.
    Spinella TC; Burdeyny V; Oprea A; Perrot TS; Barrett SP
    Cannabis Cannabinoid Res; 2024 Aug; 9(4):1006-1014. PubMed ID: 37552817
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of cannabidiol placebo on responses to an acute stressor: A replication and proof of concept study.
    Zhekova RM; Perry RN; Spinella TC; Dockrill K; Stewart SH; Barrett SP
    J Psychopharmacol; 2024 Jan; 38(1):116-124. PubMed ID: 38214314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.
    Appiah-Kusi E; Petros N; Wilson R; Colizzi M; Bossong MG; Valmaggia L; Mondelli V; McGuire P; Bhattacharyya S
    Psychopharmacology (Berl); 2020 Apr; 237(4):1121-1130. PubMed ID: 31915861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
    Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
    Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of cannabidiol placebo on amygdala-based neural responses to an acute stressor.
    Perry RN; Ethier-Gagnon MA; Helmick C; Spinella TC; Tibbo PG; Stewart SH; Barrett SP
    J Psychopharmacol; 2024 Nov; 38(11):935-948. PubMed ID: 39400103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
    Bergamaschi MM; Queiroz RH; Chagas MH; de Oliveira DC; De Martinis BS; Kapczinski F; Quevedo J; Roesler R; Schröder N; Nardi AE; Martín-Santos R; Hallak JE; Zuardi AW; Crippa JA
    Neuropsychopharmacology; 2011 May; 36(6):1219-26. PubMed ID: 21307846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A naturalistic examination of the perceived effects of cannabis on negative affect.
    Cuttler C; Spradlin A; McLaughlin RJ
    J Affect Disord; 2018 Aug; 235():198-205. PubMed ID: 29656267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental
    Bidwell LC; Martin-Willett R; Skrzynski C; Lisano J; Ortiz Torres M; Giordano G; Hutchison KE; Bryan AD
    Cannabis Cannabinoid Res; 2024 Aug; 9(4):1015-1027. PubMed ID: 38252547
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease.
    de Faria SM; de Morais Fabrício D; Tumas V; Castro PC; Ponti MA; Hallak JE; Zuardi AW; Crippa JAS; Chagas MHN
    J Psychopharmacol; 2020 Feb; 34(2):189-196. PubMed ID: 31909680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats.
    Resstel LB; Tavares RF; Lisboa SF; Joca SR; Corrêa FM; Guimarães FS
    Br J Pharmacol; 2009 Jan; 156(1):181-8. PubMed ID: 19133999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test.
    Linares IM; Zuardi AW; Pereira LC; Queiroz RH; Mechoulam R; Guimarães FS; Crippa JA
    Braz J Psychiatry; 2019; 41(1):9-14. PubMed ID: 30328956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder.
    Bolsoni LM; Crippa JAS; Hallak JEC; Guimarães FS; Zuardi AW
    Psychopharmacology (Berl); 2022 May; 239(5):1499-1507. PubMed ID: 35029706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial.
    Mastrofini GF; McFadden BA; Chandler AJ; Lints BS; Cintineo HP; Rhoades ND; Vincenty CS; Stray-Gundersen SO; Lane AD; Arent SM
    J Int Soc Sports Nutr; 2024 Dec; 21(1):2370430. PubMed ID: 38904150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.
    Bloomfield MAP; Yamamori Y; Hindocha C; Jones APM; Yim JLL; Walker HR; Statton B; Wall MB; Lees RH; Howes OD; Curran VH; Roiser JP; Freeman TP
    Psychopharmacology (Berl); 2022 May; 239(5):1539-1549. PubMed ID: 35445839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cannabidiol (CBD) on regional cerebral blood flow.
    Crippa JA; Zuardi AW; Garrido GE; Wichert-Ana L; Guarnieri R; Ferrari L; Azevedo-Marques PM; Hallak JE; McGuire PK; Filho Busatto G
    Neuropsychopharmacology; 2004 Feb; 29(2):417-26. PubMed ID: 14583744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.
    Martin-Santos R; Crippa JA; Batalla A; Bhattacharyya S; Atakan Z; Borgwardt S; Allen P; Seal M; Langohr K; Farré M; Zuardi AW; McGuire PK
    Curr Pharm Des; 2012; 18(32):4966-79. PubMed ID: 22716148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol Oil Ingested as Sublingual Drops or Within Gelatin Capsules Shows Similar Pharmacokinetic Profiles in Healthy Males.
    Johnson DA; Funnell MP; Heaney LM; Cable TG; Wheeler PC; Bailey SJ; Clifford T; James LJ
    Cannabis Cannabinoid Res; 2024 Oct; 9(5):e1423-e1432. PubMed ID: 37733294
    [No Abstract]   [Full Text] [Related]  

  • 19. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
    Hurd YL; Spriggs S; Alishayev J; Winkel G; Gurgov K; Kudrich C; Oprescu AM; Salsitz E
    Am J Psychiatry; 2019 Nov; 176(11):911-922. PubMed ID: 31109198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood.
    Manning B; Hayley AC; Catchlove S; Stough C; Downey LA
    Eur Neuropsychopharmacol; 2024 May; 82():35-43. PubMed ID: 38490083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.